Breast cancer screening: Commentary and conclusions

Preventive Medicine

Volumn 53, Issue 3, 2011, Pages 147-148

  Miller, Anthony B ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

BREAST CANCER; BREAST EXAMINATION; CANCER ADJUVANT THERAPY; CANCER MORTALITY; CANCER SCREENING; CANCER STAGING; HIGH RISK POPULATION; HORMONAL THERAPY; HUMAN; INTRADUCTAL CARCINOMA; MAMMOGRAPHY; NOTE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RISK REDUCTION; SENSITIVITY ANALYSIS;

EID: 80052656383     PISSN: 00917435     EISSN: 10960260     Source Type: Journal    
DOI: 10.1016/j.ypmed.2011.08.025     Document Type: Note

References (16)

1. Bryant H., Mai V. Impact of age-specific recommendation changes on organized breast screening programs. Prev. Med. 2011, 53:141-143.
2. Coldman A., Phillips N. Population studies of the effectiveness of mammographic screening. Prev. Med. 2011, 53:115-117.
3. de Gelder R., Fracheboud J., Heijnsdijk E.A.M., den Heeten G., Verbeek A.L.M., Broeders M.J.M., Draisma G., de Koning H.J. Digital mammography screening: weighing reduced mortality against increased overdiagnosis. Prev. Med. 2011, 53:134-140.
4. Glasziou P., Houssami N. The evidence base for breast cancer screening. Prev. Med. 2011, 53:100-102.
5. Harris R., Yeatts J., Kinsinger L. Breast cancer screening for women ages 50 to 69years a systematic review of observational evidence. Prev. Med. 2011, 53:108-114.
6. Hersch J., Jansen J., Irwig L., Barratt A., Thornton H., Howard K., McCaffery K. How do we achieve informed choice for women considering breast screening?. Prev. Med. 2011, 53:144-146.
7. Houssami N., Ciatto S. The evolving role of new imaging methods in breast screening. Prev. Med. 2011, 53:123-126.
8. Jatoi I. The impact of advances in treatment on the efficacy of mammography screening. Prev. Med. 2011, 53:103-104.
9. Miller A.B., Baines C.J. The role of clinical breast examination and breast self examination. Prev. Med. 2011, 53:118-120.
10. Mittra I. Breast cancer screening in developing countries. Prev. Med. 2011, 53:105-107.
11. Moss S. Screening women aged 40-49years. Prev. Med. 2011, 53:121-122.
12. Narod S. Screening of women at high risk for breast cancer. Prev. Med. 2011, 53:127-130.
13. US Preventive Services Task Force Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement. Ann. Intern. Med. 2009, 151:716-726.
14. Puliti D., Miccinesi G., Paci E. Overdiagnosis in breast cancer: Design and methods of estimation in observational studies. Prev. Med. 2011, 53:131-133.
15. Salas D., Ibañez J., Roman R., Cuevas D., Sala M., Ascunce N., Zubizarreta R., Xavier Castell X. Effect of start age of breast cancer screening mammography on the risk of false-positive results. Prev. Med. 2011, 53:78-81. CFPR Cumulative false positive risk group.
16. Tabar L., et al. Swedish Two-County Trial: impact of mammographic screening on breast cancer mortality during 3 decades. Radiology 2011, 260:110469. Published online June 28, 2011. 10.1148/radiol.11110469.